secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagenic Therapeutics, Inc.new (PTIX)
CIK:        0001022899
Form:       8-K/A
Filed at:   2025-09-17T23:59:59+00:00
Accession:  0001493152-25-013851
Event type: other
Sentiment:  neutral
Materiality: 0.00
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Protagenic Therapeutics updates auditor consent for Phytanix acquisition; no material news
--------------------------------------------------------------------------------

- Company files Exhibit 23.1 with consent of GreenGrowth CPAs Inc.
- Financial statements and pro forma data from prior filing remain unchanged.
- Acquisition of Phytanix Bio was previously reported on May 19, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022899/000149315225013851/0001493152-25-013851-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022899/000149315225013851/form8ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-013851

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer